Skip to main content
Clinical Trials/NL-OMON38448
NL-OMON38448
Completed
Phase 2

Phase 2 clinical feasibility study of a new Speaking Valve with a heat- and moisture exchanger (TW) for tracheotomized patients. - Clinical feasibility of the TW

Atos Medical AB0 sites20 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
tracheostomy
Sponsor
Atos Medical AB
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • is 18 years or older;
  • has a tracheostomy;
  • is spontaneously breathing;
  • has a cuffless tracheostomy tube;
  • has a tracheostomy tube with inner\- and outer cannula;
  • currently uses an HME and/or speaking valve.

Exclusion Criteria

  • is unable to handle or remove the device him/herself when needed, e.g. has decreased level of cognition or reduced mobility of the arms and/or hands;
  • is mechanically ventilated in any way;
  • has a tidal volume of less than100 ml;
  • is suffering from severe aspiration;
  • is laryngectomized; the device will block the possibility to exhale if speaking mode is unintentionally activated;
  • has severe upper airway obstruction, this may cause air trapping;
  • has thick and copious secretions, which might block the device.

Outcomes

Primary Outcomes

Not specified

Similar Trials